Assessment of Palliative Care in Lung Cancer in Turkey

Basit Öğe Kaydı
dc.contributor.authorBulbul, Y.
dc.contributor.authorOzlu, T.
dc.contributor.authorArinc, S.
dc.contributor.authorOzyurek, B. A.
dc.contributor.authorGunbatar, H.
dc.contributor.authorSenturk, A.
dc.contributor.authorBahadir, A.
dc.date.accessioned2024-04-24T17:14:29Z
dc.date.available2024-04-24T17:14:29Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: To investigate the symptoms of lung cancer in Turkey and to evaluate approaches to alleviate these symptoms. Subjects and Methods: This study included 1,245 lung cancer patients from 26 centers in Turkey. Demographic characteristics as well as information regarding the disease and treatments were obtained from medical records and patient interviews. Symptoms were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and were graded on a scale between 0 and 10 points. Data were compared using the. 2, Student t, and Mann-Whitney U tests. Potential predictors of symptoms were analyzed using logistic regression analysis. Results: The most common symptom was tiredness (n = 1,002; 82.1%), followed by dyspnea (n = 845; 69.3%), appetite loss (n = 801; 65.7%), pain (n = 798; 65.4%), drowsiness (n = 742; 60.8%), anxiety (n = 704; 57.7%), depression (n = 623; 51.1%), and nausea (n = 557; 45.5%). Of the 1,245 patients, 590 (48.4%) had difficulty in initiating or maintaining sleep. The symptoms were more severe in stages III and IV. Logistic regression analysis indicated a clear association between demographic characteristics and symptom distress, as well as between symptom distress (except nausea) and well-being. Overall, 804 (65.4%) patients used analgesics, 630 (51.5%) received treatment for dyspnea, 242 (19.8%) used enteral/parenteral nutrition, 132 (10.8%) used appetite stimulants, and 129 (10.6%) used anxiolytics/antidepressants. Of the 799 patients who received analgesics, 173 (21.7%) reported that their symptoms were under control, and also those on other various treatment modalities (dyspnea: 78/627 [12.4%], appetite stimulant: 25/132 [18.9%], and anxiolytics/antidepressants: 25/129 [19.4%]) reported that their symptoms were controlled. Conclusion: In this study, the symptoms progressed and became more severe in the advanced stages of lung cancer, and palliative treatment was insufficient in most of the patients in Turkey. (C) 2016 S. Karger AG, Baselen_US
dc.identifier.doi10.1159/000452801
dc.identifier.endpage56en_US
dc.identifier.issn1011-7571
dc.identifier.issn1423-0151
dc.identifier.issue1en_US
dc.identifier.pmid27780164
dc.identifier.scopus2-s2.0-84992688577
dc.identifier.scopusqualityQ1
dc.identifier.startpage50en_US
dc.identifier.urihttps://doi.org/10.1159/000452801
dc.identifier.urihttps://hdl.handle.net/11468/17986
dc.identifier.volume26en_US
dc.identifier.wosWOS:000391457100008
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofMedical Principles and Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLung Canceren_US
dc.subjectPalliationen_US
dc.subjectPalliative Treatmenten_US
dc.subjectSymptomsen_US
dc.subjectTreatmenten_US
dc.titleAssessment of Palliative Care in Lung Cancer in Turkeyen_US
dc.titleAssessment of Palliative Care in Lung Cancer in Turkey
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu